A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.
from All Top News -- ScienceDaily https://ift.tt/dFiztRp
Here different kind of articles available for people, simple and easy tips related to different topics.
No comments:
Post a Comment